메뉴 건너뛰기




Volumn 288, Issue 1-2, 2010, Pages 178-181

Central nervous system inflammatory demyelination after rituximab therapy for idiopathic thrombocytopenic purpura

Author keywords

Anti CD20 therapy; Central nervous system inflammatory demyelination; Idiopathic thrombocytopenic purpura; Rituximab

Indexed keywords

IMMUNOGLOBULIN; RITUXIMAB; STEROID;

EID: 71049178168     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.10.009     Document Type: Article
Times cited : (7)

References (23)
  • 1
    • 0028057250 scopus 로고
    • Depletion on B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
    • Reff M.E., Carner K., Chambers K.S., Chinn P.C., Leonard J.E., Raab R., et al. Depletion on B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83 (1994) 435-445
    • (1994) Blood , vol.83 , pp. 435-445
    • Reff, M.E.1    Carner, K.2    Chambers, K.S.3    Chinn, P.C.4    Leonard, J.E.5    Raab, R.6
  • 2
    • 0345337254 scopus 로고    scopus 로고
    • Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program
    • McLaughlin P., Grillo-Lopez A., Link B.K., Levy R., Czuczman M.S., Williams M.E., et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16 (1998) 2825-2833
    • (1998) J Clin Oncol , vol.16 , pp. 2825-2833
    • McLaughlin, P.1    Grillo-Lopez, A.2    Link, B.K.3    Levy, R.4    Czuczman, M.S.5    Williams, M.E.6
  • 3
    • 0036993543 scopus 로고    scopus 로고
    • Effective B cell depletion with rituximab in the treatment of autoimmune diseases
    • Kneitz C., Wilhelm M., and Tony H.P. Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunology 206 (2002) 519-527
    • (2002) Immunology , vol.206 , pp. 519-527
    • Kneitz, C.1    Wilhelm, M.2    Tony, H.P.3
  • 4
    • 37249092920 scopus 로고    scopus 로고
    • The potential utility of B cell-targeted biologic therapy in autoimmune diseases
    • Arkfield D.G. The potential utility of B cell-targeted biologic therapy in autoimmune diseases. Rheumatol Int 28 (2008) 205-215
    • (2008) Rheumatol Int , vol.28 , pp. 205-215
    • Arkfield, D.G.1
  • 6
    • 0028003771 scopus 로고
    • Chronic idiopathic thrombocytopenic purpura
    • George J.N., El-Havake M.A., and Raskob G.E. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 331 (1995) 207-211
    • (1995) N Engl J Med , vol.331 , pp. 207-211
    • George, J.N.1    El-Havake, M.A.2    Raskob, G.E.3
  • 7
    • 0035883071 scopus 로고    scopus 로고
    • Rituxiamb chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
    • Stasi R., Pagano A., Stipa E., and Amadori S. Rituxiamb chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98 (2001) 952-957
    • (2001) Blood , vol.98 , pp. 952-957
    • Stasi, R.1    Pagano, A.2    Stipa, E.3    Amadori, S.4
  • 8
    • 40949159424 scopus 로고    scopus 로고
    • Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis
    • Garcia-Chavez J., Majluf-Cruz A., Montiel-Cervantes L., Esparza M.G.-R., and Vela-Ojeda J. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis. Ann Hematol 86 (2007) 871-877
    • (2007) Ann Hematol , vol.86 , pp. 871-877
    • Garcia-Chavez, J.1    Majluf-Cruz, A.2    Montiel-Cervantes, L.3    Esparza, M.G.-R.4    Vela-Ojeda, J.5
  • 9
    • 49349113937 scopus 로고    scopus 로고
    • Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long term follow-up results
    • Medeot M., Zaja F., Vianelli N., Battista M., Baccarani M., Patriarca F., et al. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long term follow-up results. Eur J Haematol 81 (2008) 165-169
    • (2008) Eur J Haematol , vol.81 , pp. 165-169
    • Medeot, M.1    Zaja, F.2    Vianelli, N.3    Battista, M.4    Baccarani, M.5    Patriarca, F.6
  • 11
    • 54349123783 scopus 로고    scopus 로고
    • B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders
    • Stübgen J.P. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders. J Neuroimmunol 204 (2008) 1-12
    • (2008) J Neuroimmunol , vol.204 , pp. 1-12
    • Stübgen, J.P.1
  • 12
    • 23244441588 scopus 로고    scopus 로고
    • Multiple sclerosis following splenectomy as treatment for idiopathic thrombocytopenic purpura
    • Matsui H., Udaka F., Tamura A., Oda M., Kubori T., Nishinaka K., et al. Multiple sclerosis following splenectomy as treatment for idiopathic thrombocytopenic purpura. Intern Med 44 (2005) 747-749
    • (2005) Intern Med , vol.44 , pp. 747-749
    • Matsui, H.1    Udaka, F.2    Tamura, A.3    Oda, M.4    Kubori, T.5    Nishinaka, K.6
  • 14
    • 33745360142 scopus 로고    scopus 로고
    • The lumping and splitting of inflammatory CNS disease
    • Kerr D.A. The lumping and splitting of inflammatory CNS disease. Neurology 66 (2006) 1466-1467
    • (2006) Neurology , vol.66 , pp. 1466-1467
    • Kerr, D.A.1
  • 15
    • 34248354831 scopus 로고    scopus 로고
    • Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis
    • Wingerchuk D.M., and Lucchinetti C.F. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 20 (2007) 343-350
    • (2007) Curr Opin Neurol , vol.20 , pp. 343-350
    • Wingerchuk, D.M.1    Lucchinetti, C.F.2
  • 16
    • 59349104779 scopus 로고    scopus 로고
    • Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders
    • Petereit H., and Rubbert-Roth A. Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders. Mult Scler 15 (2009) 189-192
    • (2009) Mult Scler , vol.15 , pp. 189-192
    • Petereit, H.1    Rubbert-Roth, A.2
  • 17
    • 33846578563 scopus 로고    scopus 로고
    • The immunology of inflammatory demyelinating disease
    • Compston A. (Ed), Churchill Livingston, London
    • Wekerle H., and Lassmann H. The immunology of inflammatory demyelinating disease. In: Compston A. (Ed). McAlpine's multiple sclerosis (2006), Churchill Livingston, London 491-555
    • (2006) McAlpine's multiple sclerosis , pp. 491-555
    • Wekerle, H.1    Lassmann, H.2
  • 18
    • 33751085414 scopus 로고    scopus 로고
    • Rituximab reduces B cells and T cells in the cerebrospinal fluid of multiple sclerosis patients
    • Cross A.H., Stark J.L., Lauber J., Ramsbottom M.J., and Lyons J.-A. Rituximab reduces B cells and T cells in the cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 180 (2006) 63-70
    • (2006) J Neuroimmunol , vol.180 , pp. 63-70
    • Cross, A.H.1    Stark, J.L.2    Lauber, J.3    Ramsbottom, M.J.4    Lyons, J.-A.5
  • 19
    • 45249085670 scopus 로고    scopus 로고
    • Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells
    • Liossis S.N., and Sfikakis P.P. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin Immunol 127 (2008) 280-285
    • (2008) Clin Immunol , vol.127 , pp. 280-285
    • Liossis, S.N.1    Sfikakis, P.P.2
  • 20
    • 0033214207 scopus 로고    scopus 로고
    • Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)
    • Winkler U., Jensen M., Manzke O., Schultz H., Diehl V., and Engert A. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8). Blood 94 (1999) 2217-2224
    • (1999) Blood , vol.94 , pp. 2217-2224
    • Winkler, U.1    Jensen, M.2    Manzke, O.3    Schultz, H.4    Diehl, V.5    Engert, A.6
  • 21
    • 0026493624 scopus 로고
    • Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis
    • Myers K.J., Sprent J., Dougherty J.P., and Ron Y. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 41 (1992) 1-8
    • (1992) J Neuroimmunol , vol.41 , pp. 1-8
    • Myers, K.J.1    Sprent, J.2    Dougherty, J.P.3    Ron, Y.4
  • 22
    • 33750627447 scopus 로고    scopus 로고
    • Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment
    • Antel J., and Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J Neuroimmunol 180 (2008) 3-8
    • (2008) J Neuroimmunol , vol.180 , pp. 3-8
    • Antel, J.1    Bar-Or, A.2
  • 23
    • 41649112738 scopus 로고    scopus 로고
    • The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies
    • Supplement
    • Racke M. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies. Curr Opin Neurol 21 (2008) S9-S18 Supplement
    • (2008) Curr Opin Neurol , vol.21
    • Racke, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.